ITC Begins Section 337 Investigation on Balloon Dilation Devices
The International Trade Commission began a Section 337 investigation on allegations that German company Fiagon and U.S. parent company Hemostasis are importing and selling balloon dilation devices that infringe patents held by Entellus Medical, Stryker Corporation, and Stryker Sales, the…
Sign up for a free preview to unlock the rest of this article
If your job depends on informed compliance, you need International Trade Today. Delivered every business day and available any time online, only International Trade Today helps you stay current on the increasingly complex international trade regulatory environment.
ITC said in a May 23 notice. Entellus and Stryker filed the complaint in April and are seeking a limited exclusion order and cease and desist orders against the respondents to bar from entry "certain balloon dilation devices, systems, and components thereof" that violate the complainants' patents (see 2504230061).